Entera Bio Ltd.
ENTX
$1.21
$0.010.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.51M | -3.02M | -3.20M | -2.66M | -2.57M |
| Total Depreciation and Amortization | 7.00K | 7.00K | 8.00K | 7.00K | 8.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 678.00K | 750.00K | 901.00K | 531.00K | 600.00K |
| Change in Net Operating Assets | -270.00K | 426.00K | -211.00K | 487.00K | 555.00K |
| Cash from Operations | -3.09M | -1.83M | -2.50M | -1.63M | -1.40M |
| Capital Expenditure | -- | -27.00K | -43.00K | -29.00K | -8.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -27.00K | -43.00K | -29.00K | -8.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 130.00K | 174.00K | 251.00K | 24.00K | 13.52M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -1.00K | -75.00K | -186.00K |
| Cash from Financing | 130.00K | 174.00K | 250.00K | -51.00K | 13.34M |
| Foreign Exchange rate Adjustments | 4.00K | 7.00K | 29.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.96M | -1.68M | -2.27M | -1.71M | 11.93M |